Building on the award-winning Allia platform for image guided therapies, GE HealthCare's new Allia IGS Pulse was designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology. (Photo: Business Wire) 
News | Cath Lab
GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S. installation of a Trinias SCORE Opera C12 (ceiling mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).
News | Cath Lab
Shimadzu Medical Systems USA Installs First Trinias Score Opera Cardiac Catheterization Lab in the US

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
SpotLight Duo is the second generation Arineta CT that it will sell and service directly
News | Computed Tomography (CT)
Arineta announces SpotLight Duo

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
InfoBionic announces FDA 510(k) clearance for its MoMe ARC solution that encompasses our next generation remote ECG monitoring device and initial Bluetooth diagnostic 6-lead sensor designed to aid physicians in their diagnosis of cardiac arrhythmias
News | ECG
InfoBionic Receives FDA 510(k) Clearance for its Next Generation MoMe ARC Solution

October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug ...

Home October 13, 2023
Home
The software updates introduce fast-track analysis and a user-friendly layout for quicker review of ECG findings, enhancing efficiency for medical professionals
News | ECG
Cardiomatics Obtains the World’s 1st MDR Certification for AI-based ECG Interpretation and Implements new Functionalities

October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone ...

Home October 13, 2023
Home
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
News | Stroke
Philips and World Stroke Organization Partner to Improve Access to High-quality Stroke Care

October 12, 2023 — Royal Philips, a global leader in health technology, and the World Stroke Organization (WSO), the ...

Home October 12, 2023
Home
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays
News | Structural Heart
UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound

October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which ...

Home October 12, 2023
Home
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays
News | Cardiovascular Clinical Studies
BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II

October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home October 12, 2023
Home
Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications almost a year later
News | Coronavirus (COVID-19)
Unvaccinated Covid-19 Survivors Face Higher Risk of Heart Complications, Singapore Study Finds

October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications ...

Home October 11, 2023
Home
Combination of Tenaya’s HDAC6 inhibitors with Empagliflozin Shows Additive Benefits in Preclinical HFpEF Model and Highlights Differentiated Mechanism of Action
News | Heart Failure
Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...

Home October 11, 2023
Home
Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies, drive workflow enhancements and improve patient outcomes
News | Cardiovascular Business
GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes

October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...

Home October 11, 2023
Home
AHA Presidential Advisory graphic
News | AHA
American Heart Association Presidential Advisory defines cardiovascular-kidney-metabolic (CKM) syndrome for first time

October 11, 2023 — A newly-issued American Heart Association presidential advisory identifies the strong connections ...

Home October 10, 2023
Home
DAIC AHA Res Award Seidman Christine+E.+Seidman+M.D
Feature | Cardiovascular Clinical Studies | Christine Book
“One on One” with Christine Seidman, MD, FACC, on Hypertrophic Cardiomyopathy

October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy ...

Home October 10, 2023
Home
REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months
News
Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
The study marks a new standard for inclusive medicine with recruitment for target demographics reaching over 3x the national average
News | Cardiovascular Clinical Studies
Hawthorne Effect Announces Monumental Diversity in Patient Recruitment Data for Valvular Heart Disease Study

October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interim recruitment results for the ...

Home October 10, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now